Literature DB >> 3255102

Comparison of model and nuclear magnetic resonance structures for the human inflammatory protein C5a.

E R Zuiderweg1, J Henkin, K W Mollison, G W Carter, J Greer.   

Abstract

The model structure previously proposed for human C5a, based upon the crystal structure of the homologous protein human C3a, is compared to the solution structure of human C5a recently determined by nuclear magnetic resonance (NMR) methods in our laboratory. The general folding and helix topography of the C5a protein were modeled very well. The N-terminus, which is disordered in the C3a crystal, was correctly predicted in the C5a model both as to its being a helix and as to its docking site on the rest of the molecule. On the other hand, the NMR data show that the biologically important C-terminal residues are disordered in solution, unlike the model and the C3a crystal structure where this region was helical.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3255102     DOI: 10.1002/prot.340030302

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  4 in total

1.  Identification of receptor-binding residues in the inflammatory complement protein C5a by site-directed mutagenesis.

Authors:  K W Mollison; W Mandecki; E R Zuiderweg; L Fayer; T A Fey; R A Krause; R G Conway; L Miller; R P Edalji; M A Shallcross
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

2.  Topological distribution of four-alpha-helix bundles.

Authors:  S R Presnell; F E Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

3.  Antagonistic peptides against human anaphylatoxin C5a.

Authors:  Y Kaneko; N Okada; L Baranyi; T Azuma; H Okada
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

4.  Structure-based inhibitor design by using protein models for the development of antiparasitic agents.

Authors:  C S Ring; E Sun; J H McKerrow; G K Lee; P J Rosenthal; I D Kuntz; F E Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.